These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26136471)

  • 21. Enhanced activation of bound plasminogen on Staphylococcus aureus by staphylokinase.
    Mölkänen T; Tyynelä J; Helin J; Kalkkinen N; Kuusela P
    FEBS Lett; 2002 Apr; 517(1-3):72-8. PubMed ID: 12062412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temperature-dependent control of Staphylococcus aureus biofilms and virulence by thermoresponsive oligo(N-vinylcaprolactam).
    Lee JH; Kim YG; Lee K; Kim SC; Lee J
    Biotechnol Bioeng; 2015 Apr; 112(4):716-24. PubMed ID: 25407932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the novel oxazolidinone compound FYL-67 for preventing biofilm formation by Staphylococcus aureus.
    Wu S; Yang T; Luo Y; Li X; Zhang X; Tang J; Ma X; Wang Z
    J Antimicrob Chemother; 2014 Nov; 69(11):3011-9. PubMed ID: 24997316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.
    Jin T; Bokarewa M; Foster T; Mitchell J; Higgins J; Tarkowski A
    J Immunol; 2004 Jan; 172(2):1169-76. PubMed ID: 14707093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus: Staphylokinase.
    Bokarewa MI; Jin T; Tarkowski A
    Int J Biochem Cell Biol; 2006; 38(4):504-9. PubMed ID: 16111912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural and functional basis of plasminogen activation by staphylokinase.
    Jespers L; Vanwetswinkel S; Lijnen HR; Van Herzeele N; Van Hoef B; Demarsin E; Collen D; De Maeyer M
    Thromb Haemost; 1999 Apr; 81(4):479-85. PubMed ID: 10235424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
    Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
    Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of proteases against biofilms of Staphylococcus aureus and Staphylococcus epidermidis.
    Elchinger PH; Delattre C; Faure S; Roy O; Badel S; Bernardi T; Taillefumier C; Michaud P
    Lett Appl Microbiol; 2014 Nov; 59(5):507-13. PubMed ID: 25041576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Staphylokinase promotes the establishment of Staphylococcus aureus skin infections while decreasing disease severity.
    Kwiecinski J; Jacobsson G; Karlsson M; Zhu X; Wang W; Bremell T; Josefsson E; Jin T
    J Infect Dis; 2013 Sep; 208(6):990-9. PubMed ID: 23801604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional properties of a novel mutant of staphylokinase with platelet-targeted fibrinolysis and antiplatelet aggregation activities.
    Chen H; Mo W; Zhang Y; Su H; Ma J; Yao R; Zhang S; Ge J; Song H
    Eur J Pharmacol; 2007 Jul; 566(1-3):137-44. PubMed ID: 17451675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of endothelial cells on activity of staphylokinase.
    Ueshima S; Okada K; Matsumoto H; Takaishi T; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):522-9. PubMed ID: 8874862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo antibiofilm activity of a coral associated actinomycete against drug resistant Staphylococcus aureus biofilms.
    Bakkiyaraj D; Pandian SK
    Biofouling; 2010 Aug; 26(6):711-7. PubMed ID: 20706890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-biofilm activities of quercetin and tannic acid against Staphylococcus aureus.
    Lee JH; Park JH; Cho HS; Joo SW; Cho MH; Lee J
    Biofouling; 2013; 29(5):491-9. PubMed ID: 23668380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility.
    Jabra-Rizk MA; Meiller TF; James CE; Shirtliff ME
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1463-9. PubMed ID: 16569866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis growing in biofilms.
    Melchior MB; Fink-Gremmels J; Gaastra W
    Vet Microbiol; 2007 Nov; 125(1-2):141-9. PubMed ID: 17600640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended biofilm susceptibility assay for Staphylococcus aureus bovine mastitis isolates: evidence for association between genetic makeup and biofilm susceptibility.
    Melchior MB; van Osch MH; Lam TJ; Vernooij JC; Gaastra W; Fink-Gremmels J
    J Dairy Sci; 2011 Dec; 94(12):5926-37. PubMed ID: 22118083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel recombinant thrombolytic and antithrombotic staphylokinase variants with an RGD motif at their N-termini.
    He J; Di J; Xu R; Zhao B
    Biotechnol Appl Biochem; 2008 May; 50(Pt 1):17-23. PubMed ID: 18039183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pro-inflammatory effect of Staphylokinase contributes to community-associated Staphylococcus aureus pneumonia.
    Wang Y; Zhao N; Jian Y; Liu Y; Zhao L; He L; Liu Q; Li M
    Commun Biol; 2022 Jun; 5(1):618. PubMed ID: 35739262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular protease in Actinomycetes culture supernatants inhibits and detaches Staphylococcus aureus biofilm formation.
    Park JH; Lee JH; Kim CJ; Lee JC; Cho MH; Lee J
    Biotechnol Lett; 2012 Apr; 34(4):655-61. PubMed ID: 22160331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.